Tali‐Anne Szwebel

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · Science · 2020 · 3.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore et al. · Cell · 2020 · 920 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +5

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq et al. · The Lancet Infectious Diseases · 2017 · 577 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

Matthieu Mahévas, Viet-Thi Tran, Mathilde Roumier et al. · BMJ · 2020 · 460 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15